TUSC3

TUSC3 is an endoplasmic reticulum-resident subunit of the oligosaccharyltransferase (OST) complex that couples N-linked glycosylation to magnesium homeostasis, and its loss is linked to intellectual disability and to cancer progression (PMID:24685145, PMID:24435307, PMID:41203647). Within the OST complex, TUSC3 uses a membrane-anchored, ER-luminal thioredoxin domain to form transient mixed disulfide complexes with nascent glycoprotein substrates via a defined peptide-binding groove that recognizes peptides bearing a hydrophobic residue two positions from the substrate cysteine, thereby increasing glycosylation efficiency for a subset of glycoproteins by slowing their folding (PMID:24685145). As an OST component it also regulates G2-to-G1 glucose trimming on N-glycosylated substrates such as BMP4, acting as a dosage-sensitive gatekeeper directing substrates toward folding/secretion versus ERAD elimination (PMID:41256443). Independently, TUSC3 and its paralog MAGT1 function as magnesium transporters: at the plasma membrane both mediate cellular Mg²⁺ influx required for vertebrate development, and the two proteins are functionally redundant in immune cells, where exogenous TUSC3 rescues MAGT1-loss phenotypes (PMID:19717468, PMID:37086924). TUSC3 additionally forms an ER-localized Mg²⁺ transport complex with ERMA, and its loss depletes ER Mg²⁺, activates the PERK-eIF2α arm of ER stress, and produces synaptic dysfunction and intellectual-disability-like cognitive deficits in knockout mice that are reversible by magnesium supplementation; patient fibroblasts recapitulate the ER Mg²⁺ deficiency and ER stress (PMID:41203647). In cancers, TUSC3 loss alters the ER stress/unfolded protein response and downstream signaling, influencing proliferation, migration, epithelial-to-mesenchymal transition, and metastasis across ovarian, prostate, lung, colorectal, and hepatocellular models (PMID:24435307, PMID:23404293, PMID:25735931, PMID:30504895).

1. 2009 High

   Established TUSC3's first molecular function by showing it acts as a magnesium transporter required for cellular Mg²⁺ influx, defining a role independent of any glycosylation activity.

   Evidence Yeast complementation, siRNA knockdown with intracellular Mg²⁺ measurement, and morpholino knockdown in zebrafish with Mg²⁺ rescue

   PMID:19717468

   Open questions at the time

   • Did not resolve whether Mg²⁺ transport is direct or via a complex
   • Subcellular site of transport (plasma membrane vs ER) not distinguished
   • Relationship to OST membership unaddressed
2. 2013 Medium

   Localized TUSC3 to the ER as an OST subunit in cancer cells and tied its loss to altered glycosylation and increased proliferation/migration, framing it as a glycosylation-dependent tumor suppressor.

   Evidence Subcellular fractionation, co-immunofluorescence, reciprocal co-IP, glycosylation assays, and siRNA knockdown with functional readouts in ovarian cancer cells

   PMID:23404293

   Open questions at the time

   • Which glycoproteins are affected not defined
   • Mechanism linking glycosylation to proliferation unresolved
3. 2014 High

   Defined the catalytic-mechanistic basis of TUSC3's glycosylation role: an ER-luminal thioredoxin domain forms mixed disulfides with substrate peptides, explaining how it enhances glycosylation efficiency for select substrates.

   Evidence X-ray crystallography of two peptide-substrate complexes, biochemical binding assays, and mutagenesis

   PMID:24685145

   Open questions at the time

   • In vivo substrate repertoire not enumerated
   • Quantitative contribution to glycosylation versus other OST subunits unclear
4. 2014 Medium

   Confirmed OST complex membership in additional cancer cells and linked TUSC3 loss to ER structural change, ER stress, and Akt signaling, broadening its pathophysiological reach.

   Evidence Co-IP, glycosylation assays, and western blotting for ER stress and Akt markers in prostate cancer cell lines

   PMID:24435307

   Open questions at the time

   • Direct link between glycosylation loss and Akt activation not mechanistically established
5. 2015 Medium

   Connected TUSC3 deficiency to the ER stress response and EMT in vivo, providing a mechanism for malignant progression upon TUSC3 loss.

   Evidence Xenograft mouse model with loss-of-function, ER stress assays, and EMT marker analysis

   PMID:25735931

   Open questions at the time

   • Specific UPR branch responsible not pinpointed in this study
6. 2018 Medium

   Dissected which UPR branches drive TUSC3-loss metastasis, showing enhanced ATF6α signaling and weakened HRD1 substrate engagement converging on a suppressed p53-NM23H1/2 axis.

   Evidence miRNA gain/loss-of-function, HRD1 co-IP, UPR pathway analysis, and metastasis assays in NSCLC

   PMID:30504895

   Open questions at the time

   • Direct biochemical effect of TUSC3 on HRD1 affinity not isolated
   • Generality beyond NSCLC unknown
7. 2019 Medium

   Identified an upstream epigenetic mechanism silencing TUSC3, placing its expression under UHRF1-KAT7 control downstream of Wnt/c-Myc in colon cancer.

   Evidence UHRF1-KAT7 co-IP, ChIP for H3K14 methylation/acetylation, and gain/loss-of-function proliferation assays

   PMID:31582837

   Open questions at the time

   • Does not address TUSC3's downstream effector mechanism
   • Direct UHRF1 occupancy at TUSC3 locus dynamics partially characterized
8. 2023 Medium

   Demonstrated functional redundancy between TUSC3 and MAGT1 by rescuing MAGT1-KO immune phenotypes with exogenous TUSC3, unifying the two paralogs in Mg²⁺ transport and glycosylation.

   Evidence CRISPR/Cas9 MAGT1 knockout in NKL cells, exogenous TUSC3 rescue, epigenetic drug activation, and western blot for NKG2D/glycosylation markers

   PMID:37086924

   Open questions at the time

   • Extent of redundancy in non-immune tissues not defined
   • Whether endogenous TUSC3 normally compensates for MAGT1 in vivo unclear
9. 2025 High

   Established TUSC3's ER magnesium-transport function and its disease relevance, showing ERMA-complex formation, ER Mg²⁺ depletion, PERK-eIF2α stress, and reversible cognitive deficits, linking TUSC3 to intellectual disability.

   Evidence TUSC3 knockout mouse with behavioral testing, ER Mg²⁺ measurement, PERK-eIF2α analysis, patient fibroblast studies, and magnesium-supplementation rescue

   PMID:41203647

   Open questions at the time

   • Stoichiometry and transport mechanism of the TUSC3-ERMA complex not resolved
   • Relationship between ER Mg²⁺ role and OST glycosylation role not integrated
10. 2025 Medium

    Linked TUSC3's OST function to developmental signaling control by showing it regulates glucose trimming on N-glycosylated BMP4 to tune ER quality control and BMP output.

    Evidence Loss/gain-of-function in mammalian cells and Drosophila, biochemical glycan trimming assays, and BMP signaling readouts (preprint)

    PMID:41256443

    Open questions at the time

    • Preprint, not yet peer-reviewed
    • Direct enzymatic role of TUSC3 in trimming versus accessory role not separated
    • Substrate scope beyond BMP4/Dpp untested

• How TUSC3's two molecular activities — OST-associated glycosylation/disulfide chemistry and Mg²⁺ transport — are mechanistically coordinated within the same protein remains unresolved.
• No structure or assay distinguishing whether the thioredoxin domain and Mg²⁺ transport are coupled or independent
• Whether ER Mg²⁺ depletion versus glycosylation defects drives each disease phenotype is unseparated